Nalbuphine Hydrochloride is a small molecule drug that targets both the κ opioid receptor and μ opioid receptor.

The European Union Commission has approved Pfizer's ABRYSVO™ to protect infants and the elderly from Respiratory Syncytial Virus infections via maternal vaccination.

Homology is a qualitative concept where we determine whether two sequences are homologous or not. However, the similarity between homologous sequences can be measured using techniques such as sequence alignment. One popular method for aligning sequences is using BLAST.

Bristol Myers Squibb Co. is a pharmaceutical organization that was founded in 1887 and is headquartered in New York, United States.

RLYB116, a potential long-acting solution, is a subcutaneously administered C5 inhibitor which is currently being developed for managing patients with complement-mediated diseases.

Luliconazole is a small molecule drug that falls under the therapeutic areas of Infectious Diseases and Skin and Musculoskeletal Diseases. It primarily targets fungal CYP51A1.

Patsnap Bio Sequence Database can achieve the retrieval of antibody light and heavy chains, CDR sequence, and any CDR combination.

Bayer’s Kerendia (finerenone)  had gained approval for usage in managing chronic kidney diseases affiliated with type 2 diabetes two summers ago.

Boehringer Ingelheim GmbH is a pharmaceutical organization that was founded in 1885 and is headquartered in Rheinland-Pfalz, Germany.

Stallerges Greer has disclosed a contract with Nestle regarding the use of Palforzia ® A global agreement to treat peanut allergies.

This article summarized the latest R&D progress of Ketanserin, the Mechanism of Action for Ketanserin, and the drug target R&D trends for Ketanserin.

Exelixis Announces Positive Results from Phase 3 CABINET Pivotal Trial Evaluating Cabozantinib in Advanced Pancreatic and Extra-Pancreatic Neuroendocrine Tumors.